Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 501–600 of 1,005
Zhang, Q., Cannavicci, A., & Kutryk, M. J. B. (2022) · Stem Cells International · doi:10.1155/2022/4460041 · Cited by 19
“Studies using animalmodels of diabetes and those using ECs from healthy human subjects have revealed that hyperglycemia or exposure to high glucose levels stimulates the production of reactive oxygen species (ROS), activates the protein kinase C (PKC) pathway, induces glycation of proteins, increases polyol pathway ac…”
BackgroundSapkota, B. K., Khadayat, K., Aryal, B., Bashyal, J., Jaisi, S., & Parajuli, N. (2022) · Scientia Pharmaceutica · doi:10.3390/scipharm90030055 · Cited by 16
“Additionally, the inordinate buildup of lipids in the pancreas is a leading cause of type II diabetes, which incites the dysfunction of insulin-producing pancreatic β-cells [4].”
BackgroundChen, X., Tian, F., Sun, Z., Zeng, G., & Tang, P. (2022) · Journal of Diabetes Research · doi:10.1155/2022/9611509 · Cited by 20
Salazar, J. A. A., Valdes, M., Cruz, A., de Jesús, B. M., González, D. P., Olivares-Corichi, I. M., Cach, F. T., & Wejebe, J. E. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030909 · Cited by 15
Wang, L., Chang, T., Zhu, T., Hu, W., Wang, X., Dong, C., Sun, Y., Zhang, T., Jiang, Y., Zhao, C., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1638147 · Cited by 28
The Purinergic Landscape of Type 2 Diabetes Mellitus
García-Jacobo, R. E., Bergamin, L. S., Vultaggio-Poma, V., Thorstenberg, M. L., Tarantini, M., García-Hernández, M. H., & Virgilio, F. D. (2022) · Molecules · doi:10.3390/molecules27061838 · Cited by 19
“The main pathogenic factor in T2DM is the inability of insulin-sensitive tissues to respond to insulin, and in the progressive establishment of a condition of defective insulin secretion from pancreatic cells, which eventually leads to a stably elevated blood glucose level (hyperglycemia) [40,45].”
BackgroundInfluentialChoi, J.-H., Kim, S., Lee, E.-B., Kim, J., Jung, J.-E., Jeong, U.-Y., Kim, J.-H., Jang, H., Park, S.-Y., Kim, G.-C., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15040486 · Cited by 18
“T2D is a metabolic disorder characterized by hyperglycemia and is one of the most common chronic diseases worldwide [4].”
BackgroundPepa, G. D., Brancato, V., Costabile, G., Salamone, D., Corrado, A., Vitale, M., Cavaliere, C., Mancini, M., Salvatore, M., Luongo, D., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0605 · Cited by 17
Zhang, T., Zhang, Q., Zheng, W., Tao, T., Li, R.-L., Wang, L.-Y., Peng, W., & Wu, C. (2022) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2022.07.004 · Cited by 19
Gaikwad, D. D., Bangar, N. S., Apte, M. M., Gvalani, A., & Tupe, R. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.095 · Cited by 16
Kumar, P. P., Singh, R. P., Kumar, A., Toropova, A. P., Toropov, A. A., Devi, M., Lal, S., Sindhu, J., & Singh, D. (2022) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2022.2120068 · Cited by 16
“It is a group of metabolic abnormalities characterized by hyperglycaemia (impaired glucose tolerance) and caused mostly by impaired synthesis and secretion of insulin, or a combination of the two [2].”
BackgroundUgwor, E. I., James, A. S., Amuzat, A. I., Ezenandu, E. O., Ugbaja, V. C., & Ugbaja, R. N. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100183 · Cited by 21
Xie, Y., Zhou, Q., He, Q., Wang, X., & Wang, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.008 · Cited by 18
Antony, P., Baby, B., Aleissaee, H. M., & Vijayan, R. (2022) · Marine Drugs · doi:10.3390/md20120777 · Cited by 17
“Type 2 Diabetes Mellitus (T2DM) is a disorder characterized by defective insulin secretion or insulin resistance [1].”
BackgroundDorenkamp, M., Nasiry, M., Semo, D., Koch, S., Loeffler, I., Wolf, G., Reinecke, H., & Godfrey, R. (2023) · Cells · doi:10.3390/cells12030513 · Cited by 18
“Sera from T2DM patients contain elevated levels of a plethora of cytokines, growth factors and glucose metabolites [25].”
BackgroundLópez‐Soldado, I., Torres, A. G., Ventura, R., Martínez-Ruíz, I., Díaz‐Ramos, A., Planet, E., Cooper, D., Pazderska, A., Wanic, K., O’Hanlon, D., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102630 · Cited by 19
“T2D is characterized by insulin resistance (IR) in skeletal muscle [2], which can result from combining a genetic predisposition with obesity, a sedentary lifestyle, and an unhealthy diet [3].”
BackgroundGallic acid improves the metformin effects on diabetic kidney disease in mice
Hong, Y., Wang, J., Sun, W., Zhang, L., Xu, X., & Zhang, K. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2183726 · Cited by 20
“The patho-physiological characterization of diabetic kidney disease includes glomerular hyperfiltration, elevated serum urinary albumin, mesangial cell expansion, tubulointer-stitial fibrosis, and renal hypertrophy [4,5].”
Zhang, Z., Leng, Y., Chen, Z., Fu, X., Liang, Q., Peng, X., Xie, H., Gao, H., & Xie, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1091718 · Cited by 19
“Type 2 diabetes mellitus (T2DM) is a chronic progressive metabolic disease characterized by persistent hyperglycemia, insulin resistance and islet β-cell dysfunction (Roden and Shulman, 2019; Galicia-Garcia et al., 2020).”
BackgroundPham, T. D., Nguyen, T., Yun, H. R., Васильева, Е. А., Mishchenko, N. P., Fedoreyev, S. A., Stonik, V. A., Vu, T., Nguyen, Q. H., Cho, S. W., et al. (2023) · Marine Drugs · doi:10.3390/md21040222 · Cited by 20
Msomi, N. Z., Erukainure, O. L., Salau, V. F., Olofinsan, K. A., & Islam, M. S. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.023 · Cited by 19
The role of heat shock proteins (HSPs) in type 2 diabetes mellitus pathophysiology
Esmaeilzadeh, A., Mohammadi, V., Elahi, R., & Rezakhani, N. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108564 · Cited by 17
Álvarez-Almazán, S., Solís-Domínguez, L. C., Duperou-Luna, P., Fuerte-Gómez, T., González‐Andrade, M., Aranda-Barradas, M. E., Palacios‐Espinosa, J. F., Pérez‐Villanueva, J., Matadamas‐Martínez, F., Miranda-Castro, S. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612812 · Cited by 17
“This phenomenon is also known as insulin resistance due to the body’s inability to use insulin effectively [10].”
BackgroundJhuo, J.-Y., Tong, Z.-J., Ku, P.-H., Cheng, H.-W., & Wang, H. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122380 · Cited by 17
Diabetes among Muslims during Ramadan: A narrative review
Ochani, R. K., Shaikh, A. J., Batra, S., Pikale, G. S., & Surani, S. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i26.6031 · Cited by 18
Gallagher, D. M., O'Harte, F. P. M., & Irwin, N. (2023) · Peptides · doi:10.1016/j.peptides.2023.171096 · Cited by 22
“As such, T2DM is characterised by the impaired insulin secretion from pancreatic beta-cells and reduced insulin sensitivity of peripheral tissues, that ultimately leads to overt hyperglycaemia [23].”
Chen, J., Feng, X., Zhou, X., & Li, Y. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15294 · Cited by 18
“57,58 It is generally thought that insulin resistance is the primary cause of T2DM, preceding β -cell dysfunction.”
BackgroundDebertin, J. G., Holzhausen, E. A., Walker, D. I., Pinto‐Pacheco, B., James, K. A., Alderete, T. L., & Corlin, L. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117776 · Cited by 17
Lin, M., Xie, Y., Hong, L., Wu, S., Deng, X., Chen, Y., & Tan, X. (2023) · Public Health · doi:10.1016/j.puhe.2023.11.012 · Cited by 20
Hamedifar, H., Mirfattahi, M., Ghomi, M. K., Azizian, H., Iraji, A., Noori, M., Moazzam, A., Dastyafteh, N., Nokhbehzaim, A., Mehrpour, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50395-8 · Cited by 16
Sheng, R., Li, Y., Wu, Y., Liu, C., Wang, W., Han, X., Li, Y., Lei, L., Jiang, X., Zhang, Y., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116220 · Cited by 17
Dhamak, R. S., Salve, P. S., Tiwari, D. R., Raut, P. A., & Waghmare, D. S. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00604-6 · Cited by 16
Zhang, L., He, S., Liu, L., & Huang, J. (2024) · Phytotherapy Research · doi:10.1002/ptr.8229 · Cited by 20
“T2DM is a chronic metabolic disease characterized by hyperglycemia, and its pathophysiology is generally divided into IR in peripheral tissues and pancreatic islet dysfunction (Galicia-Garcia et al., 2020).”
Ameliorative Effects of Curcumin on Type 2 Diabetes Mellitus
Gu, Y., Zhang, Q., Zhao, Y., & Niu, Q. (2024) · Molecules · doi:10.3390/molecules29122934 · Cited by 24
“In recent years, high concentrations of curcumin have been detected in the gastrointestinal tract after oral administration, indicating that it can directly interact with the gut microbiota and exert regulatory effects [85].”
BackgroundMzimela, N., Dimba, N. R., Sosibo, A. M., & Khathi, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431405 · Cited by 22
Zuliska, S., Maksum, I. P., Einaga, Y., Kadja, G. T. M., & Irkham, I. (2024) · ADMET & DMPK · doi:10.5599/admet.2361 · Cited by 19
Sahu, B., Sahu, R., Gidwani, B., & Mishra, A. (2024) · ChemistrySelect · doi:10.1002/slct.202401604 · Cited by 17
MicroRNAs in metabolic dysfunction‐associated diseases: Pathogenesis and therapeutic opportunities
Ma, N., Tan, J., Chen, Y., Liu, Y., Li, M., & He, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202401464r · Cited by 25
“113,114 Among all patients with diabetes, type 2 diabetes has the largest number, accounting for more than 90%.”
Afraie, M., Bahrami, P., Kohnepoushi, P., Khateri, S., Majidi, L., Saed, L., Zamani, K., Mohammadi, H., Moradi, Y., & Moradpour, F. (2024) · Journal of Diabetes Research · doi:10.1155/2024/9960656 · Cited by 33
Kavya, P., Theijeswini, R. C., & Gayathri, M. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1458505 · Cited by 19
Afzal, A. H., Alam, O., Zafar, S., Alam, M. A., Ahmed, K., Khan, J. A., Khan, R., Shahat, A. A., & Alhalmi, A. (2024) · Processes · doi:10.3390/pr12112488 · Cited by 20
Studzińska-Sroka, E., Paczkowska‐Walendowska, M., Kledzik, J., Galanty, A., Gościniak, A., Szulc, P. M., Korybalska, K., & Cielecka‐Piontek, J. (2024) · Molecules · doi:10.3390/molecules29235775 · Cited by 18
“Among its various forms, type 2 diabetes is the most prevalent, affecting millions globally and posing a major burden on public health systems due to its progressive nature and associated complications [2].”
Monzon, A. D., Patton, S. R., & Koren, D. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25651 · Cited by 18
“If pancreatic beta‐cell failure occurs and there is insufficient compensatory increase in insulin secretion, eventual T2DM may develop.(66)”
BackgroundLiu, J., Zhang, Y., Qu, D. C., Zhang, H., Wang, L., Lau, C. W., Han, J., Pingcuo, D., Huang, Y., & Liu, L. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120039 · Cited by 19
Burhop, M., Schuchardt, J. P., Nebl, J., Müller, M., Lichtinghagen, R., & Hahn, A. (2022) · Nutrients · doi:10.3390/nu14020396 · Cited by 17
Fan, L., Niu, H., Zhao, L., Yao, R., He, X., Lu, B., & Pang, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112697 · Cited by 16
Ramorobi, L. M., Matowane, G. R., Mashele, S. S., Swain, S. S., Makhafola, T. J., Mfengwana, P.-M.-A. H., & Chukwuma, C. I. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113600 · Cited by 16
Shah, M., Patel, H., & Akabari, A. H. (2024) · Essential Chem · doi:10.1080/28378083.2024.2420104 · Cited by 19
Zhang, Y., Yang, X., & Wan, Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1537303 · Cited by 20
The Role of Genistein in Type 2 Diabetes and Beyond: Mechanisms and Therapeutic Potential
Kciuk, M., Kruczkowska, W., Wanke, K., Gałęziewska, J., Kołat, D., Mujwar, S., & Kontek, R. (2025) · Molecules · doi:10.3390/molecules30051068 · Cited by 19
“These processes activate pro-inflammatory pathways, resulting in the release of cytokines such as TNF-α and IL-6 [13,33].”
Tan, J., Taitz, J., Ni, D., Potier-Villette, C., Pinget, G. V., Pulpitel, T., Stanley, D., Nanan, R. K. H., & Macia, L. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102180 · Cited by 19
Mansour, A., Rahimi, H. R., Gerami, H., Khorasanian, A. S., Esmaeili, A. H., Bioky, A. A., Mohajeri‐Tehrani, M. R., Fateh, H. R., & Sajjadi‐Jazi, S. M. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01184-8 · Cited by 17
Drobiova, H., Alhamar, G., Ahmad, R., Al‐Mulla, F., & Madhoun, A. S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157568 · Cited by 205
“It is noteworthy to mention that overt T2D develops only when pancreatic β -cells fail to secrete enough insulin to compensate for this resistance [203,204].”
Mechanism of actions of probiotics on type 2 diabetes: Development and complications
Ağagündüz, D., Çelik, E., Cemali, Ö., Yeşildemir, Ö., Demirci, K. Ş., Akkuş, G., Esatbeyoglu, T., & Özoğul, F. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118421 · Cited by 21
Diabetes mellitus: Complications, emerging therapeutic targets, and evolving treatment approaches
Mohd, S., Kumar, L. L., Harish, V., Kumar, R., Chaudhary, A., & Sharma, V. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100652 · Cited by 28
Li, J., Hu, J., Yun, H., Mei, Z., Wang, X., Luo, K., Guasch‐Ferré, M., Han, X., Truong, B. M. T., Merino, J., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04105-8 · Cited by 31
Awwad, A., Poucheret, P., Idres, Y. A., Tshibangu, D. S. T., Servent, A., Ferrare, K., Lazennec, F., Bidel, L., Cazals, G., & Tousch, D. (2021) · Molecules · doi:10.3390/molecules26185566 · Cited by 17
“stress, endoplasmic reticulum stress, and amyloid stress, leading to abnormal insulin secretion and cell death in the long term [2,3].”
BackgroundQuazi, A., Patwekar, M., Faheem, I. P., & Priya, S. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns3.5189 · Cited by 16
Zhang, Z., Leng, Y., Fu, X., Yang, C., Xie, H., Yuan, H., Liang, Q., Gao, H., & Xie, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.918681 · Cited by 15
“At the same time, even if blood glucose is well controlled, the existence of metabolic memory still makes it difficult to effectively prevent the emergence and progression of T2DM and its complications (Bianchi et al., 2013; Zhang and Wu, 2014; Galicia-Garcia et al., 2020).”
BackgroundLiu, Y., Li, Y., Muema, F. W., Zhang, H., Seukep, A. J., & Guo, M. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105601 · Cited by 15
Warpechowski, J. J., Leszczyńska, P., Juchnicka, D., Olichwier, A. J., Szczerbiński, Ł., & Kretowski, A. J. (2023) · Vaccines · doi:10.3390/vaccines11071203 · Cited by 21
Majeed, M. A., Narayanan, N. K., Mundkur, L., Prakasan, P., & Nagabhushanam, K. (2023) · Nutraceuticals · doi:10.3390/nutraceuticals3030026 · Cited by 25
Phongphane, L., Radzuan, S. N. M., Bakar, M. H. A., Omar, M. T. C., Supratman, U., Harneti, D., Wahab, H. A., & Azmi, M. N. (2023) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2023.107938 · Cited by 18
Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases
Debnath, N., Yadav, P., Mehta, P. K., Gupta, P., Kumar, D., Kumar, A., Gautam, V., & Yadav, A. K. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28574 · Cited by 18
“These conditions are characterized by a complex interplay between genetic, environmental, and lifestyle factors, which can lead to dysregulation of various metabolic pathways, including glucose and lipid metabolism (Galicia ‐ Garcia et al., 2020; Jung & Choi, 2014).”
BackgroundVerapamil chronicles: advances from cardiovascular to pancreatic β-cell protection
Arefanian, H., Koti, L., Sindhu, S. T. A. K., Ahmad, R., Madhoun, A. S. A., & Al‐Mulla, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1322148 · Cited by 18
Fu, T., Sun, Y., Lu, S., Zhao, J., Dan, L., Shi, W., Chen, J., Chen, Y., & Li, X. (2024) · Diabetes Care · doi:10.2337/dc23-0978 · Cited by 17
El‐Abassy, O. M., Maged, K., Elhenawee, M., & El‐Hay, S. S. A. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.123844 · Cited by 16
Szałabska-Rąpała, K., Zych, M., Borymska, W., Londzin, P., Dudek, S., & Kaczmarczyk-Żebrowska, I. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116265 · Cited by 18
Musilanga, N., Nasib, H., Jackson, G., Shayo, F., Nhanga, C., Girukwigomba, S., Mwakibolwa, A., Henry, S., Kijusya, K., & Msonge, E. (2024) · Journal of Obesity · doi:10.1155/2024/1240457 · Cited by 24
“Te Joanna Briggs Institute quality appraisal criteria were used to evaluate the methodological quality of the included studies.”
Tonin, G., Dolžan, V., & Klen, J. (2024) · Antioxidants · doi:10.3390/antiox13030277 · Cited by 19
“Several environmental and genetic factors might lead to impaired insulin production by pancreatic β -cells and impaired insulin sensitivity in tissues, resulting in the clinical manifestation of hyperglycemia [1].”
BackgroundGu, H., Zhong, L., Zhang, Y., Sun, J., Liu, L., & Liu, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-61011-8 · Cited by 15
Ruan, W., Zhou, X., Li, J., Liu, H., Wang, T., Zhang, G., & Lin, K. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14877 · Cited by 16
“1,34 Oxidative stress and low-grade in fl ammation induced by T2DM can also trigger cardiac remodelling.”
BackgroundKumari, P., Kohal, R., Bhavana, Gupta, G. D., & Verma, S. K. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.139207 · Cited by 19
Vasileva, L. A., Gaynanova, G. A., Romanova, E. A., Petrov, K. A., Feng, C., Zakharova, L. Y., & Sinyashin, O. G. (2024) · Russian Chemical Reviews · doi:10.59761/rcr5150 · Cited by 16
Habibi, A., Letafatkar, N., Sattari, N., Nobakht, S., Rafat, Z., Moghadam, S. S., Mirdamadi, A., Javid, M., Jamilian, P., Hassanipour, S., et al. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.11.011 · Cited by 20
Ruan, M., Ai, Q., Cao, G., Ren, F., Zhang, Z., Wang, D., & Jia, Q. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106762 · Cited by 14
Maphumulo, S. C., & Pretorius, E. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1740150 · Cited by 18
Lee, D., Kim, J., Kwon, H. C., Kwon, J., Jang, D. S., & Kang, K. S. (2022) · Plants · doi:10.3390/plants11050658 · Cited by 16
“Type 2 diabetes (T2D) is a steadily growing metabolic disease worldwide, characterized by a decline in insulin secretion from pancreatic β-cells and impaired insulin function in insulin-target tissues, such as skeletal muscle [1].”
BackgroundSynthesis, Antioxidant, and Antidiabetic Activities of Ketone Derivatives of Succinimide
Waheed, B., Shah, S. M. M., Hussain, F., Khan, M. I., Zeb, A., & Jan, M. S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1445604 · Cited by 26
“Type-I diabetes mellitus is characterized by complete lack of secretion of insulin [4], while Type II diabetes mellitus (DM) caused by the resistance of peripheral tissues to the action of insulin and inadequate compensatory secretion of insulin [5].”
BackgroundWilson, S. M. G., Peterson, E. J., Gaston, M. E., Kuo, W., & Miles, M. P. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.08.002 · Cited by 17
Mohammed, A. A., Abo–Elmatty, D. M., Abdel-Azeem, R., Raafat, K., Hussein, M., El-Ansary, A. R., Hafez, W., Hassan, H. A., Nassar, N. A., Selim, N. M., et al. (2023) · Healthcare · doi:10.3390/healthcare11040485 · Cited by 18
Effects of Vitamin D Supplementation in Diabetic Kidney Disease: A Systematic Review
Ullmann, T. D. O. E. S., Ramalho, B. J., Laurindo, L. F., Tofano, R. J., Rubira, C. J., Guiguer, É. L., Barbalho, S. M., Flato, U. A. P., Sloan, K. P., & Araújo, A. C. (2023) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2023.05.006 · Cited by 17
Jooste, B. R., Kolivas, D., Brukner, P., & Moschonis, G. (2023) · Nutrients · doi:10.3390/nu15204362 · Cited by 14
“Fasting Blood Glucose (FBG) 6–6.9 mmol/L (100–125 mg/dL) >7 mmol/L (126 mg/dL) HbA1c 5.7 − 6.4% (39–46 Non-modifiable risk factors that can increase an individual’s susceptibility to T2DM include genetics [1], age [8], and gestational diabetes in women [9].”
BackgroundInfluentialGhosh, N., & Verma, S. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2422005 · Cited by 19
“Diabetes mellitus, a progressive metabolic disorder caused by high blood glucose levels, remains a significant global health challenge 1 .”
Mechanisms of endurance and resistance exercise in type 2 diabetes mellitus: A Narrative review
Zhao, X., Huang, F., Sun, Y., & Li, L. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151731 · Cited by 19
Aslan, Z., Yılmaz, E., Pulat, N., Şeker, A., Ertem, A., Demirhan, M., Gündoğdu, S., Arslan, M., & Demir, Y. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2756 · Cited by 15
Fitrianingsih, S. P., Kurniati, N. F., Fakih, T. M., & Adnyana, I. K. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e149156 · Cited by 17
“The disease is associated with serious complications, including cardiovascular disease, nephropathy, neuropathy, and retinopathy, making it a major cause of morbidity and mortality (Galicia-Garcia et al. 2020).”
Probosari, E., Subagio, H. W., Heri-Nugroho, Rachmawati, B., Muis, S. F., Tjandra, K. C., Adiningsih, D., & Winarni, T. I. (2025) · Nutrients · doi:10.3390/nu17152489 · Cited by 22
“T2DM is a chronic metabolic disorder marked by persistently high blood sugar levels brought on by insulin resistance, impaired insulin secretion, or both [7,8].”
Biscetti, F., Cecchini, A. L., Rando, M. M., Nardella, E., Gasbarrini, A., Massetti, M., & Flex, A. (2021) · Atherosclerosis Plus · doi:10.1016/j.athplu.2021.10.003 · Cited by 17
Otani, K., Funada, H., Teranishi, R., Okada, M., & Yamawaki, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084228 · Cited by 14
“Type 2 diabetes (T2D) is a metabolic disease in which blood glucose levels become chronically high due to decreased insulin secretion and/or insulin resistance [3].”
BackgroundZou, X., Xiao, H., Bai, X., Zou, Y., Hu, W., Lin, X., Zhu, C., Liang, Y., & Xiong, W. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0011 · Cited by 18
Park, J.-E., & Han, J.-S. (2022) · Nutrients · doi:10.3390/nu14183815 · Cited by 16
“Insulin resistance is a significantly dangerous constituent in the progression of diabetes, and its prevalence is rapidly increasing [5].”
BackgroundRazzaki, T. S., Weiner, A., & Shukla, A. P. (2022) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s328056 · Cited by 16
“by both genetic and environmental factors, and results from the combination of insufficient insulin secretion by pancreatic islet beta (ß)-cells and peripheral insulin resistance in the skeletal muscle, adipose tissue, and liver.(4) Insulin”
Yan, W., Xiao, L., Ying, Y., Li, J., & Fan, Z. (2023) · International Journal of Oral Science · doi:10.1038/s41368-022-00202-3 · Cited by 16
“Type 2 DM (T2DM) exceeds 90% of diabetes mellitus case and is characterised by a lack of insulin secretion from pancreatic islet β-cells, insufficient compensatory insulin secretory responses, and tissue insulin resistance (IR).(2) According to research on both humans and animals, T2DM causes an increase in the suscep…”
BackgroundRojanaverawong, W., Wongmanee, N., & Hanchang, W. (2023) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2023.28.1.30 · Cited by 20
Kim, H.-S., Lee, D., Seo, Y.-H., Ryu, S. M., Lee, A. Y., Moon, B. C., Kim, W.-J., Kang, K. S., & Lee, J. H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041239 · Cited by 14
“Its result is postprandial hyperglycemia, which must be controlled to prevent T2D [1].”
BackgroundInfluentialAdemola, S. A., Bamikole, O. J., & Amodu, O. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1028303 · Cited by 19
“Obesity is a major risk factor for type 2 diabetes (51).”
BackgroundDetection of Biomarker Using Aptasensors to Determine the Type of Diabetes
Mulyani, D. E., & Maksum, I. P. (2023) · Diagnostics · doi:10.3390/diagnostics13122035 · Cited by 16
Karuga, F. F., Jaromirska, J., Malicki, M., Sochal, M., Szmyd, B. M., Białasiewicz, P., Strzelecki, D., & Gabryelska, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1208886 · Cited by 14
Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics
Fotea, S., Ghiciuc, C. M., Ștefănescu, G., Cianga, A. L., Mihai, C. M., Lupu, A., Butnariu, L. I., Stârcea, I. M., Șalaru, D. L., Mocanu, A., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13142436 · Cited by 18
“…(T2DM) is a complex, chronic metabolic disease that consists of hyperglycemia as a result of insulin resistance and a variable grade of impairment in insulin secretion due to β -cell dysfunction (lipotoxicity, inborn genetic defect or acquired from glucose toxicity or other mechanisms) [24].”
BackgroundSun, Y., Mehmood, A., Giampieri, F., Battino, M. A., & Chen, X. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2255666 · Cited by 17
“Offspring of patients with T2DM resulting from insulin resistance and impaired glucose tolerance are also at risk of developing diabetes (Galicia-Garcia et al. 2020).”
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.